Farshad Foroudi

Radiation oncologist. Director of Department. Professor. Past President of TROG. MRI in RT. Dad. Cyclist. Opinions are my own.

[Wee Loon Ong @weeloonong]

Health services session at #RANZCR2025
@reshmajagsi @jeremymillar @FarshadForoudi

[Farshad Foroudi @FarshadForoudi]

Very much valued having Ronan as part of our team. The Irish trained ROs and RTs add a lot to the growth our team.

[Gerry Hanna @gerryhanna]

Completing the fellowship session and staying with the #brachytherapy and #Aussie 🇦🇺 theme

#SLICR Donal Hollywood awardee, Dr Ronan Joyce updates the @RCSI_Irl #RadOnc ASM on his fellowship at the @Austin_Health in @Melbourne

[Trans Tasman Radiation Oncology Group @TROGfightcancer]

Congratulations to Prof @FarshadForoudi who was awarded our LIfetime Member Award at the TROG Annual Scientific Meeting last week. Prof Foroudi has been an active, committed TROG member for more than 15 years contributing across many areas; a well deserved recognition.

[Farshad Foroudi @FarshadForoudi]

@TROGfightcancer Honoured to received life membership award from TROG. A great organisation working to provide evidence and improving cancer patient care.

[Trans Tasman Radiation Oncology Group @TROGfightcancer]

Congrats to the TROG 14.02 RAIDER team for publishing promising findings in European Urology - the Phase II trial is studying if it's possible to safely deliver complex adaptive radiotherapy for bladder cancer. Read the paper:
https://t.co/0VdsmNZeVC
@FarshadForoudi @ICR_London

[Follow us on Bluesky @ICR-CTSU @ICR_CTSU]

The chief investigator is Prof @robert_huddart. Prof @EmmaHall71 is the scientific lead. The trial was funded by @CRUK in the UK and was in collaboration with @TROGfightcancer in Australia with Prof @FarshadForoudi and New Zealand with Dr @Yarraben. https://t.co/gAfhijISnU

[Janice Yeh @janiceyehRO]

Wonderful summary on #oligometastatic disease and #oligoprogression in #breastcancer by excellent speakers Prue Francis and @drspdavid
@BCTrialsANZ #bct2024
Looking forward to AVATAR-2 ⚡️⚡️ @PeterMacRadOnc

[Farshad Foroudi @FarshadForoudi]

A/Prof @drspdavid presenting on ablative treatments (SABR) for oligometastatic breast cancer at #bct2024. A great debate with Prof Prue Francis (medical oncologist)

[Farshad Foroudi @FarshadForoudi]

Lots of fun. Local practice remains predominately hypofractionated radiotherapy.

[Breast Cancer Trials @BCTrialsANZ]

In Great Debate 1 at #BCT2024, Associate Professor @FarshadForoudi and Professor Elinor Sawyer debated the statement - That 5 Fraction Whole Breast RT is the Standard of Care for Early Stage, Node Negative Breast Cancer.

[Trans Tasman Radiation Oncology Group @TROGfightcancer]

Please join us in welcoming A/Prof. Sweet Ping Ng as the deputy chair of the TROG Scientific Committee (TSC).

Sweet Ping is the Director of Radiation Oncology Research at Austin Health and has worked on numerous TROG clinical trials and committees.

[Trans Tasman Radiation Oncology Group @TROGfightcancer]

Congratulations to Prof. Boon Chua & her team for their success in receiving funding for their ductal carcinoma in-situ (DCIS) research.

The team received $1.1 million to improve the treatment outcomes of women diagnosed with DCIS of the breast.

Congratulations to all involved!

[Jenna Dean @Curlz1702]

Thanks so much @ClairePoolec @LeechmMichelle @maevekearne @lauremarignol @Forde_Elizabeth for hosting us! Such a great day hearing about all of your amazing projects! @ASMIRTorg

[Trans Tasman Radiation Oncology Group @TROGfightcancer]

Starting day two at the #TROGASM24 with the @Elekta breakfast session!

The session, led by Sweet Ping Ng, focused on the Unity MR-Linac Global Registry Collaboration and Clinical Update.

#TROG2024 #TROGCancerResearch

[Jenna Dean @Curlz1702]

@SweetPingNg presenting at the @Elekta_ANZ breakfast session at @TROGfightcancer ASM. Amazing to see what you can see and achieve with the @Elekta Unity!

[Farshad Foroudi @FarshadForoudi]

Associate Professor @SweetPingNg presenting on Victorian MR Linac based at Austin Health. At TROG ASM in Newcaslte. Multiple indications for this state wide technology. @Elekta @Austin_Health @TROGfightcancer @TargetingCancer #TROGASM24

[Shankar Siva @_ShankarSiva]

1/ For #KidneyCancerAwareness month @TheLancetOncol has a 50-day full link to @TROGfightcancer FASTRACK II! https://t.co/p5SVg9Ktvl. Thank you @CancerAustralia, @ANZUPtrials, @VarianMedSys. A new #radiotherapy standard of care option for inoperable primary #kidneycancer #radonc

[Farshad Foroudi @FarshadForoudi]

@charles_gillham @gerryhanna @QUBelfast @BelfastTrust @CancerInstIRE Congratulations @gerryhanna .

[Peter Mac Radiation Oncology @PeterMacRadOnc]

@JMIRO_Journal @JoaquinJCabrera @weeloonong @FarshadForoudi Great work by super-⭐️ #radonc registrar, @theresekang_ ! 👏👏👏

Open access: https://t.co/xgsJMeqKR0

@weeloonong @phillips_ce @FarshadForoudi @PeterMacCC @JMIRO_Journal @WileyGlobal @RANZCRcollege @svporceddu

[Farshad Foroudi @FarshadForoudi]

Dr Maike Trommer presenting at #RANZCR2023 on research on obesity and outcomes of cervix cancer. Using patient planning scans in 88 Patients with FIGO IIB-IVA cancers. High fat mass lived significantly shorter.